Cargando…
Best practice model for outpatient psychiatric pharmacy practice, part 1: Development of initial attribute statements
INTRODUCTION: A 2019 survey identified significant variability of practice characteristics among outpatient psychiatric pharmacists (OPPs). No published model establishes which attributes constitute best practice for OPPs. By developing a consensus for best practice model attributes, OPPs can work t...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
College of Psychiatric & Neurologic Pharmacists
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009820/ https://www.ncbi.nlm.nih.gov/pubmed/35582320 http://dx.doi.org/10.9740/mhc.2022.04.057 |
_version_ | 1784687346930679808 |
---|---|
author | Silvia, Richard J. Lee, Kelly C. Payne, Gregory H. Ho, Jessica Cobb, Carla Ansara, Elayne D. Ross, Clint A. |
author_facet | Silvia, Richard J. Lee, Kelly C. Payne, Gregory H. Ho, Jessica Cobb, Carla Ansara, Elayne D. Ross, Clint A. |
author_sort | Silvia, Richard J. |
collection | PubMed |
description | INTRODUCTION: A 2019 survey identified significant variability of practice characteristics among outpatient psychiatric pharmacists (OPPs). No published model establishes which attributes constitute best practice for OPPs. By developing a consensus for best practice model attributes, OPPs can work toward consistent, effective patient care. This project aimed to develop attribute statements for a best practice model for OPPs providing direct patient care. METHODS: Board Certified Psychiatric Pharmacists and American Association of Psychiatric Pharmacists (AAPP) members were questioned using a 5-phase (P1-P5) survey and summit approach. The phases were: P1, broad ideation survey; P2, 10-person summit to develop draft statements; P3, survey of the draft statements for acceptance; P4, summit to resolve review feedback; and P5, survey of AAPP membership to confirm the finalized statements. RESULTS: P1 survey results generated a list of 143 possible attributes that informed the P2 summit, which were refined to 28 statements. P3 survey results confirmed at least 70% agreement with each statement. The P4 summit evaluated all P3 survey results and made significant modifications to 4 statements. Informal feedback was sought with other stakeholders, and supporting narratives and references were developed to provide clarity regarding the intent of each statement. Finalized statements and supporting narratives were confirmed in the P5 survey. DISCUSSION: The 28 attribute statements were developed over 18 months by gathering input and consensus through multiple modalities, including 3 surveys, 2 summit meetings, and numerous informal feedback requests. The agreement on the attribute statements was consistently high across all phases. The final attribute statements are presented elsewhere in this issue. |
format | Online Article Text |
id | pubmed-9009820 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | College of Psychiatric & Neurologic Pharmacists |
record_format | MEDLINE/PubMed |
spelling | pubmed-90098202022-05-16 Best practice model for outpatient psychiatric pharmacy practice, part 1: Development of initial attribute statements Silvia, Richard J. Lee, Kelly C. Payne, Gregory H. Ho, Jessica Cobb, Carla Ansara, Elayne D. Ross, Clint A. Ment Health Clin Original Research INTRODUCTION: A 2019 survey identified significant variability of practice characteristics among outpatient psychiatric pharmacists (OPPs). No published model establishes which attributes constitute best practice for OPPs. By developing a consensus for best practice model attributes, OPPs can work toward consistent, effective patient care. This project aimed to develop attribute statements for a best practice model for OPPs providing direct patient care. METHODS: Board Certified Psychiatric Pharmacists and American Association of Psychiatric Pharmacists (AAPP) members were questioned using a 5-phase (P1-P5) survey and summit approach. The phases were: P1, broad ideation survey; P2, 10-person summit to develop draft statements; P3, survey of the draft statements for acceptance; P4, summit to resolve review feedback; and P5, survey of AAPP membership to confirm the finalized statements. RESULTS: P1 survey results generated a list of 143 possible attributes that informed the P2 summit, which were refined to 28 statements. P3 survey results confirmed at least 70% agreement with each statement. The P4 summit evaluated all P3 survey results and made significant modifications to 4 statements. Informal feedback was sought with other stakeholders, and supporting narratives and references were developed to provide clarity regarding the intent of each statement. Finalized statements and supporting narratives were confirmed in the P5 survey. DISCUSSION: The 28 attribute statements were developed over 18 months by gathering input and consensus through multiple modalities, including 3 surveys, 2 summit meetings, and numerous informal feedback requests. The agreement on the attribute statements was consistently high across all phases. The final attribute statements are presented elsewhere in this issue. College of Psychiatric & Neurologic Pharmacists 2022-04-14 /pmc/articles/PMC9009820/ /pubmed/35582320 http://dx.doi.org/10.9740/mhc.2022.04.057 Text en © 2022 CPNP. The Mental Health Clinician is a publication of the College of Psychiatric and Neurologic Pharmacists. https://creativecommons.org/licenses/by-nc/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Silvia, Richard J. Lee, Kelly C. Payne, Gregory H. Ho, Jessica Cobb, Carla Ansara, Elayne D. Ross, Clint A. Best practice model for outpatient psychiatric pharmacy practice, part 1: Development of initial attribute statements |
title | Best practice model for outpatient psychiatric pharmacy practice, part 1: Development of initial attribute statements |
title_full | Best practice model for outpatient psychiatric pharmacy practice, part 1: Development of initial attribute statements |
title_fullStr | Best practice model for outpatient psychiatric pharmacy practice, part 1: Development of initial attribute statements |
title_full_unstemmed | Best practice model for outpatient psychiatric pharmacy practice, part 1: Development of initial attribute statements |
title_short | Best practice model for outpatient psychiatric pharmacy practice, part 1: Development of initial attribute statements |
title_sort | best practice model for outpatient psychiatric pharmacy practice, part 1: development of initial attribute statements |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009820/ https://www.ncbi.nlm.nih.gov/pubmed/35582320 http://dx.doi.org/10.9740/mhc.2022.04.057 |
work_keys_str_mv | AT silviarichardj bestpracticemodelforoutpatientpsychiatricpharmacypracticepart1developmentofinitialattributestatements AT leekellyc bestpracticemodelforoutpatientpsychiatricpharmacypracticepart1developmentofinitialattributestatements AT paynegregoryh bestpracticemodelforoutpatientpsychiatricpharmacypracticepart1developmentofinitialattributestatements AT hojessica bestpracticemodelforoutpatientpsychiatricpharmacypracticepart1developmentofinitialattributestatements AT cobbcarla bestpracticemodelforoutpatientpsychiatricpharmacypracticepart1developmentofinitialattributestatements AT ansaraelayned bestpracticemodelforoutpatientpsychiatricpharmacypracticepart1developmentofinitialattributestatements AT rossclinta bestpracticemodelforoutpatientpsychiatricpharmacypracticepart1developmentofinitialattributestatements |